Literature DB >> 18641461

Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases.

Vanessa Ruiz-Bonilla1, Eusebio Perdiguero, Lionel Gresh, Antonio L Serrano, Mònica Zamora, Pedro Sousa-Victor, Mercè Jardí, Erwin F Wagner, Pura Muñoz-Cánoves.   

Abstract

Adult skeletal muscle is a very stable tissue containing a small population of myofiber-associated quiescent satellite cells compared with late embryonic/neonatal skeletal muscle, which contains highly proliferating myoblasts and small actively growing myofibers, suggesting that specific regulatory pathways may control myogenesis at distinct developmental stages. The p38 MAPK signaling pathway is central for myogenesis, based on studies using immortalized and neonatal primary myoblasts in vitro. However, the contribution of this pathway to adult myogenesis has never been investigated. Four p38 isoforms (p38alpha, p38beta, p38gamma and p38delta) exist in mammalian cells, being p38alpha and p38gamma the most abundantly expressed isoforms in adult skeletal muscle. Given the embryonic/neonatal lethality of p38alpha-deficient mice, here we investigate the relative contribution of p38beta, p38gamma and p38delta to adult myogenesis. Regeneration and myofiber growth of adult muscle proceeds with similar efficiency in mice lacking p38beta, p38gamma and p38delta as in wild-type control mice. In agreement with this, there is no difference in adult primary myoblasts behavior in vitro among the different genotypes. Importantly, the pattern of p38 activation (ascribed to p38alpha) remains unperturbed during satellite cell-mediated myogenesis in vitro and adult muscle regeneration in wild type and p38beta-, p38gamma- and p38delta-deficient mice, rendering p38alpha as the essential p38 isoform sustaining adult myogenesis. This study constitutes the first analysis addressing the functionality of p38beta, p38gamma and p38delta in satellite cell-dependent adult muscle regeneration and growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641461     DOI: 10.4161/cc.7.14.6273

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Improved insulin sensitivity with calorie restriction does not require reduced JNK1/2, p38, or ERK1/2 phosphorylation in skeletal muscle of 9-month-old rats.

Authors:  Naveen Sharma; Abhijit D Bhat; Anketse D Kassa; Yuanyuan Xiao; Edward B Arias; Gregory D Cartee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-19       Impact factor: 3.619

2.  SOCS2 inhibited mitochondria biogenesis via inhibiting p38 MAPK/ATF2 pathway in C2C12 cells.

Authors:  Lu Gan; Zhenjiang Liu; Zhenzhen Zhang; Xiaobo Yang; Jing Liu; Chao Sun
Journal:  Mol Biol Rep       Date:  2013-12-19       Impact factor: 2.316

3.  Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.

Authors:  Jonathan Oliva; Scott Galasinski; Amelia Richey; Amy E Campbell; Marvin J Meyers; Neal Modi; Jun Wen Zhong; Rabi Tawil; Stephen J Tapscott; Francis M Sverdrup
Journal:  J Pharmacol Exp Ther       Date:  2019-06-12       Impact factor: 4.030

Review 4.  Regulatory interactions between muscle and the immune system during muscle regeneration.

Authors:  James G Tidball; S Armando Villalta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-10       Impact factor: 3.619

5.  The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment.

Authors:  Natasha C Chang; Marie-Claude Sincennes; Fabien P Chevalier; Caroline E Brun; Melanie Lacaria; Jessica Segalés; Pura Muñoz-Cánoves; Hong Ming; Michael A Rudnicki
Journal:  Cell Stem Cell       Date:  2018-04-19       Impact factor: 24.633

6.  The p38 MAPK family, a pushmi-pullyu of skeletal muscle differentiation.

Authors:  Andrew B Lassar
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

7.  p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.

Authors:  Mark A Gillespie; Fabien Le Grand; Anthony Scimè; Shihuan Kuang; Julia von Maltzahn; Vanessa Seale; Ana Cuenda; Jeffrey A Ranish; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

Review 8.  p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.

Authors:  Ramkumar Menon; John Papaconstantinou
Journal:  Expert Opin Ther Targets       Date:  2016-08-04       Impact factor: 6.902

9.  Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function.

Authors:  Madeleine Scharf; Stefan Neef; Robert Freund; Cornelia Geers-Knörr; Mirita Franz-Wachtel; Almuth Brandis; Dorothee Krone; Heike Schneider; Stephanie Groos; Manoj B Menon; Kin-Chow Chang; Theresia Kraft; Joachim D Meissner; Kenneth R Boheler; Lars S Maier; Matthias Gaestel; Renate J Scheibe
Journal:  Mol Cell Biol       Date:  2013-04-22       Impact factor: 4.272

Review 10.  Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration.

Authors:  Valentina Guasconi; Pier Lorenzo Puri
Journal:  Trends Cell Biol       Date:  2009-04-23       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.